News | News By Subject | News by Disease News By Date | Search News

Transplant rejection News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
FDA Accepts Veloxis Pharmaceuticals A/S (VELO)'s New Drug Application For Envarsus®     3/14/2014
Alexion Pharmaceuticals Inc. (ALXN)'s Soliris Shows Potential for Organ Transplants     9/12/2013
Novartis Pharmaceuticals Corporation (NVS) Receives US FDA Approval for Zortress(R) to Prevent Organ Rejection in Adult Kidney Transplant Recipients     4/22/2010
FDA Approves New Dosing Recommendations For Wyeth (WYE)'s (Jobs) RAPAMUNE In High Immunologic Risk Renal Transplant Patients     2/2/2007
Argos Therapeutics, Inc. And Beckman Coulter, Inc. (BEC) Sign License Agreement     4/26/2006
Enzon Pharmaceuticals, Inc. (ENZN) Returns Rights To Transplantation Product To Fresenius Biotech GmbH     1/6/2006
Regeneration Technologies Inc. (RTIX) Issues Voluntary Tissue Recall     10/14/2005
Tutogen Medical Inc. (TTG) Issues Voluntary Product Recall     10/13/2005
LifeCell Corporation (LIFC) Voluntarily Recalls Product From One Tissue Recovery Organization     10/7/2005
Chiron Corporation (CHIR) Release: PULMINIQ -- Cyclosporine, USP -- Inhalation Solution Receives Majority Support On Safety And Tie Vote On Efficacy From FDA Advisory Committee -- Chiron Expects FDA Decision On New Therapy For Lung-Transplant Patients By Mid-July     6/7/2005
US FDA Staff Question Chiron Corporation (CHIR) Lung Transplant Drug     6/3/2005
Serono International S.A. (SRA) And NovImmune SA To Collaborate In Development Of Two Novel Treatments For Autoimmune Diseases; Up To $105 Million     5/17/2005
Odyssey Pharmaceuticals, Inc. Announces FDA Approval For Custodiol HTK Solution For Perfusion And Flushing Of Donor Pancreata, In Addition To Previously Approved Liver, Kidney And Heart Transplants     3/29/2005

News from Around the Web
Researchers Develop Key Brake For Immune Cells In Petri Dish; Hope For Easier Organ Transplantation?, Helmholtz Centre for Infection Research And Medical School Hannover Study     6/18/2009
Cancer Drug Effectively Treats Transplant Rejections, University of Cincinnati     12/29/2008
'Invisible' Transplant Organs Now In Sight, Hammersmith Hospital And California Institute of Technology Study     11/14/2008
Therapy Helps Hard-To-Transplant Get A New Kidney, Georgetown University Hospital Study     10/14/2008
New Laboratory Technique Improves Success In 'Highly Sensitized' Kidney Transplants, Developed By Cedars-Sinai     9/23/2008
Genetic Mutation That May Predict Organ Rejection Identified By Children's Hospital of Pittsburgh Researchers     9/16/2008
Embryonic Stem Cells Reduce Transplantation Rejection, University of Iowa Study     9/16/2008
Animal Tissue Rejection Advance in University of Leeds Study     7/21/2008
Combo Therapy Makes More Kidney Transplants Possible in Cedars-Sinai Study     7/17/2008
Immune Molecule Key to Preventing Organ Rejection, Medical College of Georgia Study     6/24/2008
Immune Molecule that Plays a Powerful Role in Avoiding Organ Rejection Identified in Medical College of Georgia Study     6/20/2008
Anti-Rejection Drug May Boost Diabetes In Kidney Transplant Patients; Those Treated With Wyeth (WYE)'s Sirolimus Faced Up To 66% Increased Risk Of Disease After Operation, University of British Columbia Study     5/30/2008
Anti-Rejection Drug May Increase Risk Of Diabetes After Kidney Transplant, University of British Columbia Study Shows     5/27/2008
Rejecting Defeat -- Scientist Triumphs After Setback In Kidney Transplant Method; Doctors Report on Organ Transplant Patients Who Didn't Need Lifelong Immune-Suppressing Drugs     1/25/2008
Doctors Report Transplant Breakthrough     1/24/2008

Press Releases
Omeros (OMER) Announces Positive Data From OMS721 Phase II Trial In Patients With Stem Cell Transplant-Associated Thrombotic Microangiopathy     10/20/2016
New Study Evaluates Masimo (MASI) PVI As A Predictor Of Fluid Responsiveness In Patients Undergoing Liver Transplantation     7/21/2016
Exosome Diagnostics Discovers World’s First Kidney Transplant Rejection Signature From A Simple Urine Test     5/12/2016
Kamada Ltd. (KMDA) Reports 2016 First Quarter Financial Results     5/9/2016
Immucor Announces The Launch Of kSORT To Support The Health Of Kidney Transplant Recipients     5/3/2016
ProtoKinetix Inc. (PKTX.OB) Release: AAGP Improves Results In Stem Cells Transplanted In Retina Tissue By 300%     5/2/2016
TRACT Therapeutics Received FDA Approval For A Phase II Trial Using A Patient’s Immune Cells To Prevent Organ Rejection     4/29/2016
TSRI Scientists Identify Molecular Markers Of Kidney Transplant Rejection     3/16/2016
Miltenyi Biotec, Inc. And Cesca Therapeutics' Subsidiary Totipotentrx Announce Multi-Year Commercial Agreement For Bone Marrow Transplantation     10/28/2015
CytoDyn Files An IND And Full Protocol For Phase II Study In GvHD     10/20/2015
Chimerix (CMRX) Presents Preliminary Data On Brincidofovir In Liver Transplant Recipients With Adenovirus Infections At IDWeek In San Diego     10/7/2015
St. Jude Children's Research Hospital And Cesca Therapeutics Enter Into Collaboration Agreement Targeting Bone Marrow Transplantation     10/1/2015
Chimerix (CMRX) Presents New Research On Hospital Readmission Rates In Hematopoietic Cell Transplant Recipients     9/21/2015
Pluristem Therapeutics (PSTI) Completed Successful Meeting With The U.S. FDA In Preparation For Filing An IND For PLX-R18 To Treat Incomplete Hematopoietic Recovery After Bone Marrow Transplantation     9/9/2015
Veloxis Pharmaceuticals A/S (VELO) Envarsus XR Granted Orphan Drug Status By FDA For Kidney Transplant Rejection Prophylaxis     8/17/2015

//-->